Quick Answer
WEST PHARMACEUTICAL SERVICES INC reported Cash And Cash Equivalents At Carrying Value of $791.30 million for the year ending 2025.
- WEST PHARMACEUTICAL SERVICES INC showed an increase of +63.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from WEST PHARMACEUTICAL SERVICES INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $97.10 million | Q1 2011: $94.60 million | Q2 2011: $110.40 million | Q1 2012: $100.20 million | Q2 2012: $107.00 million | Q3 2012: $143.20 million | Q1 2013: $175.00 million | Q2 2013: $190.60 million | Q3 2013: $221.70 million | Q1 2014: $230.00 million | Q2 2014: $226.70 million | Q3 2014: $246.80 million | Q1 2015: $207.10 million | Q2 2015: $252.00 million | Q3 2015: $256.80 million | Q1 2016: $178.10 million | Q2 2016: $202.70 million | Q3 2016: $205.90 million | Q1 2017: $169.40 million | Q2 2017: $226.60 million | Q3 2017: $269.30 million | Q1 2018: $199.80 million | Q2 2018: $225.50 million | Q3 2018: $297.30 million | Q1 2019: $265.50 million | Q2 2019: $326.70 million | Q3 2019: $396.00 million | Q1 2020: $335.30 million | Q2 2020: $445.90 million | Q3 2020: $519.40 million | Q1 2021: $483.70 million | Q2 2021: $576.20 million | Q3 2021: $688.00 million | Q1 2022: $667.70 million | Q2 2022: $718.50 million | Q3 2022: $729.00 million | Q1 2023: $886.30 million | Q2 2023: $796.30 million | Q3 2023: $898.60 million | Q1 2024: $601.80 million | Q2 2024: $446.20 million | Q3 2024: $490.90 million | Q1 2025: $404.20 million | Q2 2025: $509.70 million | Q3 2025: $628.50 million.
- Over the full 17 years of available data (2010 to 2025), WEST PHARMACEUTICAL SERVICES INC's Cash And Cash Equivalents At Carrying Value has grown by 618.1%.
- Historical annual values: Fiscal year 2025: $791.30 million | Fiscal year 2024: $484.60 million | Fiscal year 2023: $853.90 million | Fiscal year 2022: $894.30 million | Fiscal year 2021: $762.60 million | Fiscal year 2020: $615.50 million | Fiscal year 2019: $439.10 million | Fiscal year 2018: $337.40 million | Fiscal year 2017: $235.90 million | Fiscal year 2016: $203.00 million | Fiscal year 2015: $274.60 million | Fiscal year 2014: $255.30 million | Fiscal year 2013: $230.00 million | Fiscal year 2012: $161.90 million | Fiscal year 2011: $91.80 million | Fiscal year 2011: $161.90 million | Fiscal year 2010: $110.20 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: